Status:
COMPLETED
Low Nicotine Content Cigarettes in Vulnerable Populations: Opioid Use Disorder
Lead Sponsor:
University of Vermont
Collaborating Sponsors:
Food and Drug Administration (FDA)
National Institute on Drug Abuse (NIDA)
Conditions:
Tobacco Use Disorder
Eligibility:
All Genders
21-70 years
Phase:
PHASE2
Brief Summary
Prevalence of smoking among individuals with opioid use disorder (OUD) is six-fold that of the general US adult population. The mortality rate of opioid-dependent smokers is four times that of opioid-...
Eligibility Criteria
Inclusion
- Maintained on opioid medication
- 21 to 70 years old
Exclusion
- Not maintained on opioid medication
- Under 21 years old
- Over 70 years old
Key Trial Info
Start Date :
October 18 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 27 2023
Estimated Enrollment :
326 Patients enrolled
Trial Details
Trial ID
NCT04092101
Start Date
October 18 2020
End Date
November 27 2023
Last Update
March 30 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins University
Baltimore, Maryland, United States, 21287
2
Shirley Plucinski
Burlington, Vermont, United States, 05401